AIM ImmunoTech Inc. (AIM) stock
AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.14−0.01 (-3.36%)
Close on Nov 13, 2026Market cap $4.37MP/E –Yield –
AIM ImmunoTech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
AIM ImmunoTech's operating cash flow for the twelve months ending Sep 30, 2026 was -$12.23M. For fiscal 2025 it was -$10.96M. The highest annual figure on record is -$7.38M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.96M | – |
| FY2024 | Dec 31, 2024 | -$14.89M | – |
| FY2023 | Dec 31, 2023 | -$21.27M | – |
| FY2022 | Dec 31, 2022 | -$16.11M | – |
| FY2021 | Dec 31, 2021 | -$13.97M | – |
| FY2020 | Dec 31, 2020 | -$10.37M | – |
| FY2019 | Dec 31, 2019 | -$9.07M | – |
| FY2018 | Dec 31, 2018 | -$10.64M | – |
| FY2017 | Dec 31, 2017 | -$7.94M | – |
| FY2016 | Dec 31, 2016 | -$7.38M | – |
| FY2015 | Dec 31, 2015 | -$16.05M | – |
| FY2014 | Dec 31, 2014 | -$13.96M | – |
| FY2013 | Dec 31, 2013 | -$16.90M | – |
| FY2012 | Dec 31, 2012 | -$13.14M | – |
| FY2011 | Dec 31, 2011 | -$10.10M | – |
| FY2010 | Dec 31, 2010 | -$11.89M | – |
| FY2009 | Dec 31, 2009 | -$9.30M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.93M | – |
| Q2 FY2026 | Jun 30, 2026 | -$4.59M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.72M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.99M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.08M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.53M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.36M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.96M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.11M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.01M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.82M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.76M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.67M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.07M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.97M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.31M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.76M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.75M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.46M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.72M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.05M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.85M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.99M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.28M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.25M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.29M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.54M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.78M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.46M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.42M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.98M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.70M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.54M | – |
| Q4 FY2017 | Dec 31, 2017 | -$760.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.88M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.31M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.99M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.10M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.99M | – |
See a number that looks wrong?